Trulicity Lawsuit Settlements for Vision Side Effects | 2026
Source · Sokolove Law
TLDR
Sokolove Law reports that at least 247 lawsuits alleging a connection between GLP-1 medications and NAION-related vision loss have been consolidated in federal litigation. Its article discusses claims against Trulicity maker Eli Lilly, but the provided excerpt does not report any settlements.
- 01The firm says lawsuits allege Eli Lilly failed to warn Trulicity users about a potential NAION risk.
- 02The article reports over 1,300 visual-impairment reports involving Trulicity submitted to the FDA.
- 03According to the article, the consolidated litigation names Eli Lilly and Novo Nordisk as defendants in Pennsylvania federal court.
Why it matters Editorial
The article highlights safety allegations and litigation involving GLP-1 medications, presented by a law firm soliciting potential clients.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.